Mass Tort brief
Mass Tort: AI Hallucinations, Teva Bellwethers, and Golda Class Actions
Tel Aviv courts throw out fake AI filings while Teva prepares for a critical Georgia bellwether trial and Meta caps youth addiction liability.
Mass Tort
Mass Tort
Teva's upcoming September bellwether trial in Georgia will test 4,000 IUD injury claims — setting the financial benchmark for eventual global settlement negotiations.
BackgroundMultidistrict litigation consolidates thousands of personal injury claims into a single federal court for pre-trial proceedings and representative bellwether trials. Teva secured a defense verdict in the first trial earlier this year, but thousands of claims remain unsettled.
- Over 4,000 consolidated US lawsuits allege Teva's copper birth control device is defectively designed, causing painful breakage and requiring surgical intervention.
- Federal Judge Leigh Martin May scheduled the second bellwether trial, Robere v. Teva, for September 28 in Atlanta to re-test jury sentiment.
- A second defense victory would sharply depress claim values, whereas a large plaintiff verdict could force Teva into comprehensive global settlement talks.
Mass Tort
A Tel Aviv court threw out a ₪110M class action against AIG Israel — exposing how unverified AI legal citations can instantly destroy high-stakes litigation.
BackgroundClass action lawsuits in Israel carry significant legal exposure for consumer-facing insurance firms. Generative legal AI tools can produce convincingly formatted case citations, yet unverified filings risk immediate judicial dismissal and heavy cost sanctions.
- An Israeli judge spotted five non-existent court precedents generated by artificial intelligence in the plaintiff's legal submissions, prompting an immediate judicial inquiry.
- The court ordered the plaintiff to pay ₪20,000 in legal costs and issued a stern warning against unverified AI use in judicial filings.
- The original lawsuit claimed AIG Israel breached statutory consumer regulations regarding customer telephone wait times, but the procedural misconduct effectively terminated the case.
Mass Tort
Golda faces a certified ₪350M class action over sugar-free labeling — exposing Israeli food chains to massive consumer liability for misleading health claims.
BackgroundIsraeli consumer protection regulations set strict statutory limits defining permissible sugar content for food items labeled sugar-free. Golda operates over 100 branches across Israel, making it the country's dominant retail ice cream chain.
- Laboratory testing showed coffee and hazelnut flavors contained 6.6 grams of sugar per 100 grams, far exceeding the 0.5 gram legal maximum.
- Judge Iris Rabinovitch-Brun rejected Golda's defense that consumers understood 'sugar-free' meant 'no added sugar', allowing class certification to proceed.
- Golda temporarily pulled the disputed flavors from store displays, facing severe brand damage and potential statutory compensation across millions of past customer sales.
Mass Tort